Last reviewed · How we verify

NCT03465267

Comparisons of Two Types of Armeo Robot for Upper Extremities

Status unknown NA Last updated 14 March 2018
What this trial tests

NA trial testing Armeo power in Stroke in 20 participants. Status unknown.

Timeline
1 June 2017
Primary endpoint
31 December 2018
31 December 2018

Quick facts

Lead sponsorNational Rehabilitation Center, Seoul, Korea
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment20
Start date1 June 2017
Primary completion31 December 2018
Estimated completion31 December 2018
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

National Rehabilitation Center, Seoul, Korea — full company profile →

Who can join

19 and older, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparison of two types of robot (Armeo power vs Armeo spring) for upper extremity rehabilitation on upper extremity function

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. A comparison of the effects and usability of two exoskeletal robots with and without robotic actuation for upper extremity rehabilitation among patients with stroke: a single-blinded randomised controlled pilot study.
    Park JH, Park G, Kim HY, Lee JY, et al · · 2020 · cited 21× · PMID 33076952 · DOI 10.1186/s12984-020-00763-6
  2. A comparison of the effects and usability of two exoskeletal robots with and without robotic actuation for upper extremity rehabilitation among patients with stroke: a single-blinded randomised controlled pilot study
    Park JH, Park G, Kim HY, Lee J, et al · · 2020 · DOI 10.21203/rs.3.rs-24709/v3

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other National Rehabilitation Center, Seoul, Korea trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03465267.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing